ADC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
Archives of Disease in Childhood 1996;75:17-24; doi:10.1136/adc.75.1.17
Copyright © 1996 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993. The French Langerhans' Cell Histiocytosis Study Group.

In a retrospective study involving 32 haematology/oncology departments in France, 348 cases of Langerhans' cell histiocytosis diagnosed between 1983 and 1993 were collated. The percentage of males was 56.4%. Median age at diagnosis was 30.2 months. The median follow up was 35.5 months. Initially, 108 patients (31%) had isolated unifocal or bifocal bone involvement, 67 (19%) had isolated multifocal bone involvement, 136 (39%) had soft tissue involvement without organ dysfunction, and 37 (11%) had organ dysfunction. Two thirds of the sites of involvement diagnosed throughout the course of the disease were present at diagnosis, while the remaining one third appeared during a relapse. Treatment was tailored to the individual patient and was extremely varied, hampering any comparison of regimens. Vinblastine with or without steroids was the most common regimen when systemic chemotherapy was used for the first episode (246/348). Twenty four of the 216 patients received VP 16 as first line treatment. Two patients with progressive multiorgan relapse, despite the use of several drugs, underwent bone marrow transplantation and are alive and disease free 60 and 22 months later. Altogether 21.9% of patients had sequelae, including diabetes insipidus in 17.5% of cases. The overall survival rate is 91.7% (confidence interval 90.7 to 95%) three years after diagnosis. In the univariate analysis, age less than 1 year, ear, nose, and throat, cutaneous, lymph node, liver, spleen, lung, marrow and intestinal involvement, male sex, progressive episodes, the absence of response, and partial responses, were associated with a poor vital prognosis. In a multivariate analysis of prognostic factors, poor early outcome emerged as the most important parameter, closely linked to other poor outcome features such as young age and organ dysfunction. It identified a small number of patients with a poor initial response to treatment, for whom intensive treatment should be assessed in a phase II trial.




This article has been cited by other articles:


Home page
 Am. J. Roentgenol.Home page
N. D'Ambrosio, S. Soohoo, C. Warshall, A. Johnson, and S. Karimi
Craniofacial and Intracranial Manifestations of Langerhans Cell Histiocytosis: Report of Findings in 100 Patients
Am. J. Roentgenol., August 1, 2008; 191(2): 589 - 597.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
H. Gadner, N. Grois, U. Potschger, M. Minkov, M. Arico, J. Braier, V. Broadbent, J. Donadieu, J.-I. Henter, R. McCarter, et al.
Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification
Blood, March 1, 2008; 111(5): 2556 - 2562.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
H. Prosch, N. Grois, M. Wnorowski, M. Steiner, and D. Prayer
Long-Term MR Imaging Course of Neurodegenerative Langerhans Cell Histiocytosis
AJNR Am. J. Neuroradiol., June 1, 2007; 28(6): 1022 - 1028.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
E. Hait, M. Liang, B. Degar, J. Glickman, and V. L. Fox
Gastrointestinal Tract Involvement in Langerhans Cell Histiocytosis: Case Report and Literature Review
Pediatrics, November 1, 2006; 118(5): e1593 - e1599.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
D. Prayer, N. Grois, H. Prosch, H. Gadner, and A. J. Barkovich
MR Imaging Presentation of Intracranial Disease Associated with Langerhans Cell Histiocytosis
AJNR Am. J. Neuroradiol., May 1, 2004; 25(5): 880 - 891.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Donadieu, M.-A. Rolon, I. Pion, C. Thomas, F. Doz, M. Barkaoui, A. Robert, A. Deville, F. Mazingue, M. David, et al.
Incidence of Growth Hormone Deficiency in Pediatric-Onset Langerhans Cell Histiocytosis: Efficacy and Safety of Growth Hormone Treatment
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 604 - 609.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
V. R. Nanduri, L. Lillywhite, C. Chapman, L. Parry, J. Pritchard, and F. Vargha-Khadem
Cognitive Outcome of Long-Term Survivors of Multisystem Langerhans Cell Histiocytosis: A Single-Institution, Cross-Sectional Study
J. Clin. Oncol., August 1, 2003; 21(15): 2961 - 2967.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. Beaumont, M. Sanz, P.M. Carli, F. Maloisel, X. Thomas, L. Detourmignies, A. Guerci, N. Gratecos, C. Rayon, J. San Miguel, et al.
Therapy-Related Acute Promyelocytic Leukemia
J. Clin. Oncol., June 1, 2003; 21(11): 2123 - 2137.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
H. Demirci, C. L. Shields, J. A. Shields, and R. C. Eagle Jr
Bilateral Sequential Orbital Involvement by Eosinophilic Granuloma
Arch Ophthalmol, July 1, 2002; 120(7): 978 - 979.
[Full Text] [PDF]

Home page
 J Child NeurolHome page
A. A. Jarquin-Valdivia and J. Buchhalter
Delayed Diagnosis of Pediatric Langerhans' Cell Histiocytosis: Case Report and Retrospective Review of Pediatric Cases Seen at Mayo Clinic
J Child Neurol, July 1, 2001; 16(7): 535 - 538.
[Abstract] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
S. L. Stein, A. S. Paller, P. R. Haut, and A. J. Mancini
Langerhans Cell Histiocytosis Presenting in the Neonatal Period: A Retrospective Case Series
Arch Pediatr Adolesc Med, July 1, 2001; 155(7): 778 - 783.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
F. Geissmann, Y. Lepelletier, S. Fraitag, J. Valladeau, C. Bodemer, M. Debre, M. Leborgne, S. Saeland, and N. Brousse
Differentiation of Langerhans cells in Langerhans cell histiocytosis
Blood, March 1, 2001; 97(5): 1241 - 1248.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
G. Siegal, M. Luntz, H. Duchmann, M. Fradis, D. Attias, Z. Fridman, and I. Misselevitch
Quiz Case 1
Arch Otolaryngol Head Neck Surg, January 1, 2001; 127(1): 78 - 80.
[Full Text] [PDF]

Home page
 ThoraxHome page
A. Tazi, P. Soler, and A. J Hance
Rare diseases bullet 9: Adult pulmonary Langerhans' cell histiocytosis
Thorax, May 1, 2000; 55(5): 405 - 416.
[Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. A. Kaltsas, T. B. Powles, J. Evanson, P. N. Plowman, J. E. Drinkwater, P. J. Jenkins, J. P. Monson, G. M. Besser, and A. B. Grossman
Hypothalamo-Pituitary Abnormalities in Adult Patients with Langerhans Cell Histiocytosis: Clinical, Endocrinological, and Radiological Features and Response to Treatment
J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1370 - 1376.
[Abstract] [Full Text]

Home page
 J Child NeurolHome page
M.-A. Barthez, E. Araujo, and J. Donadieu
Langerhans Cell Histiocytosis and the Central Nervous System in Childhood: Evolution and Prognostic Factors. Results of a Collaborative Study
J Child Neurol, March 1, 2000; 15(3): 150 - 156.
[Abstract] [PDF]

Home page
 Am. J. Roentgenol.Home page
F. Fernandez-Latorre, F. Menor-Serrano, S. Alonso-Charterina, and J. Arenas-Jimenez
Langerhans' Cell Histiocytosis of the Temporal Bone in Pediatric Patients: Imaging and Follow-Up
Am. J. Roentgenol., January 1, 2000; 174(1): 217 - 221.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
P. W. Bauer, C. B. MacDonald, G. F. Domanowski, and N. S. Fuleihan
Pathologic Quiz Case 2
Arch Otolaryngol Head Neck Surg, December 1, 1998; 124(12): 1395 - 1395.
[Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
A. Mohn, C. L Acerini, T. D Cheetham, S. L Lightman, and D. B Dunger
Hypertonic saline test for the investigation of posterior pituitary function
Arch. Dis. Child., November 1, 1998; 79(5): 431 - 434.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Maghnie, G. Bossi, C. Klersy, G. Cosi, E. Genovese, and M. Aricò
Dynamic Endocrine Testing and Magnetic Resonance Imaging in the Long Term Follow-Up of Childhood Langerhans Cell Histiocytosis
J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3089 - 3094.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. TAZI, L. MONTCELLY, A. BERGERON, D. VALEYRE, J.-P. BATTESTI, and A. J. HANCE
Relapsing Nodular Lesions in the Course of Adult Pulmonary Langerhans Cell Histiocytosis
Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 2007 - 2010.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
S J Howell, P Wilton, and S M Shalet
Growth hormone replacement in patients with Langerhan's cell histiocytosis
Arch. Dis. Child., May 1, 1998; 78(5): 469 - 473.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1996 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health